Dáil Éireann Debate, Tuesday - 22 September 2015
754. Deputy Michael Healy-Rae asked the Minister for Health if he will address a matter (details supplied) regarding the human papilloma virus vaccination programme; and if he will make a statement on the matter. [30550/15]
View answerThe Human Papilloma Virus (HPV) vaccine protects against two high risk types of HPV that cause 73% of all cervical cancers. Trials of the vaccines involved found that they provide nearly 100% protection against cervical infections with HPV types 16 and 18 and the cervical cell changes that these persistent infections can cause.
The HPV programme is a long-term investment that will protect girls from developing cervical cancer in adulthood. It is too early in the process to have statistics on the long-term impacts.
